United States · FDA National Drug Code directory
Lorazepam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68071-3242_1cc164c1-e967-71b1-e063-6394a90ad5e7
- Product NDC
- 68071-3242
- Form
- TABLET
- Composition / generic term
- Lorazepam
- Labeler
- NuCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20071001
- Source listing expiry
- 20261231
Source-listed ingredients
- LORAZEPAM — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 TABLET in 1 BOTTLE (68071-3242-3) · 68071-3242-3
- 4 TABLET in 1 BOTTLE (68071-3242-4) · 68071-3242-4
- 15 TABLET in 1 BOTTLE (68071-3242-5) · 68071-3242-5
- 6 TABLET in 1 BOTTLE (68071-3242-6) · 68071-3242-6
- 8 TABLET in 1 BOTTLE (68071-3242-8) · 68071-3242-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →